Intellectual Framework
Layered Systems Medicine
A proposed framework for understanding how biological dysfunction may organize across hierarchical layers before producing recognizable disease.
The Diagnostic Gap
Current Diagnostic Models and the Pre-Disease Window
Standard evaluation is well-designed to detect disease at the clinical layer — the layer where symptoms appear and where diagnostic categories are defined. The question the framework addresses is what precedes that layer: whether biological dysfunction organizes across deeper hierarchical layers before meeting conventional diagnostic criteria. The clinical evidence suggesting this is real is extensive. A formal model for understanding it systematically is what Layered Systems Medicine proposes to provide.
The Biological Layer Model
DNA expression, gene regulation, heritable risk patterns, and epigenetic modification by environment and experience.
Energy production, cellular signaling, oxidative capacity, and intracellular metabolic function.
Hormone synthesis and conversion, nutrient metabolism, inflammatory mediator production, and substrate regulation.
Immune system, endocrine system, autonomic nervous system, and gastrointestinal function — operating as integrated systems.
Named disease, measurable symptoms, diagnostic categories, and the clinical findings that trigger conventional evaluation.
Standard evaluation primarily operates at Layer 5. The framework proposes that chronic dysfunction often originates at Layers 2–4.
The Central Mechanism
Biological Layer Mismatch
Layer mismatch occurs when diagnosis or treatment targets a different biological layer than where dysfunction is actually organized. A patient with Hashimoto's thyroiditis has TSH measured — a pituitary layer signal — while the dysfunction is organized at the immune layer (autoimmune attack), the metabolic layer (impaired T4-to-T3 conversion), and the cellular layer (energy deficiency). Evaluating and treating at the pituitary layer while three deeper layers are active is layer mismatch. The clinical consequence is predictable: partial response, plateau, or recurrence. The downstream expression is managed. The upstream driver persists.
Symptoms are treated here as clinical information — not only as disease labels, but as indicators that may reflect dysfunction organized at other biological levels. The framework proposes that persistent symptoms in the context of normal conventional evaluation may represent dysfunction at layers the evaluation was not designed to reach.
Key Concepts
Diagnostic Information Gradient (DIG)
The further a symptom is from its originating layer, the harder it is to trace. Diagnostic signal degrades across biological layers — which is why conventional evaluation, operating at the clinical layer, misses dysfunction organized at the cellular or metabolic layer.
Multi-Domain Evidence Framework (MDEF)
A structured approach to integrating heterogeneous clinical and biomarker evidence across biological domains for diagnostic inference. Addresses how clinicians can systematically evaluate each layer rather than defaulting to the most visible findings.
Layered Dysfunction Assessment (LDA)
A clinical scoring instrument derived from LSM, designed for systematic patient assessment and research application. Operationalizes the framework for use at the bedside and in clinical trials.
Academic Development
Layered Systems Medicine is being developed as a formal, peer-reviewed academic framework. A portfolio of nine manuscripts in active development and submission targets Nature Medicine, BMJ, JAMA Internal Medicine, Annals of Internal Medicine, and the Journal of General Internal Medicine. The framework is designed to be falsifiable, operationalizable, and testable in clinical research settings.